Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-15-019819
Filing Date
2015-02-27
Accepted
2015-02-27 18:02:49
Documents
1
Period of Report
2015-02-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 14974
  Complete submission text file 0001209191-15-019819.txt   16514
Mailing Address 801 CORPORATE CENTER DRIVE SUITE 210 RALEIGH NC 27607
Business Address 801 CORPORATE CENTER DRIVE SUITE 210 RALEIGH NC 27607 919 582 9050
BIODELIVERY SCIENCES INTERNATIONAL INC (Issuer) CIK: 0001103021 (see all company filings)

EIN.: 352089858 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BIODELIVERY SCIENCES INTL, INC. 801 CORPORATE CENTER DRIVE, SUITE 210 RALEIGH NC 27607
Business Address
Finn Andrew L (Reporting) CIK: 0001302103 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31361 | Film No.: 15661145